Gene Query: GMIP

Dataset Description Geneva Score
The splicing factor RBM25 controls MYC activity in Acute Myeloid Leukemia 35.81
Pitfalls in Single Clone CRISPR-Cas9 Mutagenesis to Fine-map Regulatory Intervals 33.34
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition [RNA-Seq] 30.8
Selective modulation of inflammatory Natural Killer (NK) cell phenotypes following histone H3K27 demethylase inhibition 30.8
Quantitative analysis of bi-modal binding of BET proteins at promoters predicts I-BET sensitivity 27.96
Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis [d7+d14] 26.18
RNA-seq profiling of the human neutrophil genome during PMA- and E. coli encounter-induced activation 23.97
Human neutrophil genome during PMA- and E. coli encounter-induced activation 23.97
Characterization of Human Pegivirus Infection in Liver Transplantation Recipients 23.35
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation 21.75
EZH2 inhibitor efficacy in non-Hodgkin lymphoma does not require suppression of H3K27 mono-methylation [RNA-Seq] 21.75
Selective suppression of endothelial cytokine production by progesterone receptor [RNA-seq] 21.27
Selective suppression of endothelial cytokine production by progesterone receptor 21.27
Genome wide transcriptome analysis of palbociclib or GSK3326595 treated A375 cells [Palbociclib_GSK_RNASeq] 20.98
TNF response in promyelocytic and granulocytic forms of HL60/S4 cells 20.45
Rapid neurogenesis through transcriptional activation in human stem cell (RNA-Seq) 19.24
Charaterization of genetic alterations and gene expression signatures found in BCR-ABL inhibitor-resistant KCL-22 subpopulations and single clones 17.74
The role of TFEB in retinoid induced differentiation of NB4 APL leukemic cells (shTFEB) 17.68
Intrahepatic MAIT cell gene expression revealed by RNA-seq 17.34
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition 16.03
Sensitivity and engineered resistance of myeloid leukemia cells to BRD9 inhibition (RNA-seq) 16.03
Targeting JNK Pathway Expands Human Hematopoietic Stem Cells 15.96
Transcriptional effect of ETV1 knockdown in melanoma cells 15.79
Glutaminolysis is a metabolic dependency in FLT3 ITD Acute Myeloid Leukemia unmasked by FLT3 Tyrosine Kinase Inhibition 15.56
RNA-Seq and ATAC-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 15.3
RNA-Seq in SMARCD2 k/d NB4 cells with/without ATRA differentiation 15.3
Gene expression changes in THP1 cells at day 2 and 4 following shRNA knock-down of RUVBL2 14.6
Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis [ZNF787] 14.58
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) [RNA-seq] 14.52
Co-expression of CD163 and CD141 Identifies Human Circulating IL-10-Producing Dendritic Cells (DC-10) 14.52
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis 14.43
MKL1 augments megakaryocyte maturation by enhancing the SRF regulatory axis [RNA-seq] 14.43
HuR controls apoptosis and activation response without effects on cytokine 3′ UTRs 13.15
Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance [RNA-seq] 13.14
Expression analysis of primary human monocytes stimulated with an anti-TLR10 mAb (5C2C5) 13.12
Tafazzin Regulates Cell State by Modulating Phosphatidylethanolamine and Phosphatidylserine levels 12.92
RNA-seq of MLLT3-overexpressing cultued HSPC, compared to non-overexpressing and uncutured FL-HSPC [RNAseq_MLLT3_OE] 12.88
Mllt3 Governs Self-Renewal And Engraftment Of Human Hematopoietic Stem Cells 12.88
RNAseq to determine gene expression changes following depletion of SETDB1 in THP-1 AML Cells 12.82
Global Bidirectional Transcription of the Epstein-Barr Virus Genome During Reactivation 12.78
SRSF2 mutations impair hematopoiesis and alter exon recognition 12.65
Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection 12.6
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo 12.14
The hematopoietic master transcription factor PU.1 requires its interaction with the SWI/SNF remodeler to access chromatin de novo [RNA-seq] 12.14
CASZ1 directly regulates expression of myogenic genes through regional epigenetic modifications to induce muscle and rhabdomyosarcoma cell differentiation 12.11
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells [RNA-Seq] 12.05
CTCF and CohesinSA-1 Mark Active Promoters and Boundaries of Repressive Chromatin Domains in Primary Human Erythroid Cells 12.05
Transcriptome-wide identification of CELF2 functional targets in T cells 11.99
ZFR coordinates crosstalk between RNA decay and transcription in innate immunity 11.81
Identification of the O-GlcNAc-regulated alternative splicing events by performing RNA sequencing on HeLa cells with altered O-GlcNAc level. 11.71
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL 11.45
Genetic analysis of Ikaros target genes and tumor suppressor function in BCR-ABL1+ pre-B ALL [RNA-seq] 11.45
PHF20 readers link methylation of histone H3K4 and p53 with H4K16 acetylation 11.31
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis [bulk RNA-Seq] 11.29
Endothelial TGFb signaling drives vascular inflammation and atherosclerosis 11.29
Whole transcriptome sequencing identifies increased CXCR2 expression in PNH granulocytes 11.23
Expression and functions of long noncoding RNAs during human T helper cell differentiation 11.02
Gene expression changes associated with resistance to tagraxofusp (SL-401) 10.57
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation 10.5
Benzotriazoles reactivate latent HIV-1 through inactivation of STAT5 SUMOylation (RNA-Seq) 10.5
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia 10.37
Che-1 is targeted by c-Myc to sustain proliferation in pre-B-cell acute lymphoblastic leukemia [RNA-seq] 10.37
Targeting MTHFD2 in Acute Myeloid Leukemia 10.2
Global gene expression profile of dasatinib-resistant RCH-ACV cells 9.7
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile [mRNA-Seq] 9.38
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile 9.38
Induction of Prolonged Early G1 Arrest by CDK4/CDK6 Inhibition Reprograms Lymphoma Cells for Durable PI3Kδ Inhibition Through PIK3IP1 9.26
Transcriptomic insights into human decidual and peripheral blood CD8 T cells 9.26
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation (RNA-Seq) 9.25
Topoisomerase 1 inhibition suppresses inflammatory genes and protects from death by inflammation 9.25
Evolution of an lncRNA leads to a primate specific modulation of alternative splicing 9.17
MYCi975 regulates MYC target genes 9.08
Identifying ASCL1 target genes in primary GBM stem cell cultures [RNA-seq] 9.06
Characterization of macrophage - cancer cell crosstalk in estrogen receptor positive and triple-negative breast cancer 9.04
Pharmacologic inhibition of STAT5 in AML 9.02
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies 8.91
Discovery of first-in-class reversible dual small molecule inhibitors against G9a and DNMTs with in vivo activity in hematological malignancies [RNA-Seq] 8.91
RNA-seq in acute myeloid leukemia (AML) cells with and without knockdown of METTL14 8.68
Immunological Imbalance in Fibrodysplasia Ossificans Progressiva Revealed by PBMC Transcriptome Analysis 8.63
Global epigenomic reconfiguration during mammalian brain development 8.61
Homolog-selective degradation as a strategy to probe the function of CDK6 in AML 8.56
The landscape of alternative splicing in aggressive prostate cancers 8.55
Transcriptomics of human macrophages upon infection with Legionella pneumophila and two isogenic mutants, LamA and AnkH using RNA-seq 8.49
Global analysis of alternative splicing regulated by RBM10 8.38
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia 8.33
Endogenous retroviruses are a source of oncogenic enhancers in acute myeloid leukemia [RNA-Seq] 8.33
RNA-seq analysis of AML cells in response to ASLAN003 8.3
A map of gene expression in neutrophil-like cell lines 8.23
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics 8.22
Generation of a Panel of Induced Pluripotent Stem Cells From Chimpanzees: a Resource for Comparative Functional Genomics (RNA-Seq) 8.22
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation [RNA-Seq] 8.18
IFN-g Regulates mTORC1, Cellular Metabolism and mRNA Translation to Potentiate Inflammatory Macrophage Activation 8.18
Identification and characterization of circular RNAs as a new class of putative biomarkers in human blood 8.09
Transcription control by the ENL YEATS domain in acute leukemia [RNA-seq] 8.05
Transcription control by the ENL YEATS domain in acute leukemia 8.05
RNA-seq analysis of FET cells treated with RSPO1 or TGFβ1 7.99
Stretch-Enhancers Delineate Disease-Associated Regulatory Nodes in T Cells 7.95
RNA-seq transcriptional profiling in human primary fetal and adult CD34+ hematopoietic stem/progenitor cells (HSPCs) erythroid progenitor cells (ProEs) 7.9
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_KD] 7.89
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells 7.87
RNA expression in primary huamn muscle cells treated with 1,25(OH)2D3 or vehicle 7.81
mRNA and miRNA expression in primary human muscle cells treated with 1,25(OH)2D3 or vehicle 7.81
Comparative genome-wide analysis of human BM IL3Rα-high precursors show a more MΦ-, DC- and OC committed gene expression profile, as compared to IL3Rα-low precursors 7.77
Stem and effector CD8 T-cells from human cancers 7.67
Allogeneic mature human dendritic cells generate superior alloreactive regulatory T cells in the presence of IL-15 7.66
Enhanced T cell responses to IL-6 in type 1 diabetes are associated with early clinical disease and increased IL-6 receptor expression 7.55
Transcriptional Modulation of Human Endogenous Retroviruses in Primary CD4+ T Cells Following Vorinostat Treatment 7.54
RNAseq of PRMT4KD in human cord blood derived CD34+ cells 7.54
Integrative analysis identifies lincRNAs up- and downstream of neuroblastoma driver genes (ALK) 7.51
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia 7.42
A TFIID-SAGA perturbation that targets MYB and suppresses acute myeloid leukemia (RNA-seq) 7.42
Activation of HOTTIP lncRNA perturbs HSC function leading to AML like disease 7.26
Landscape and variation of RNA secondary structure across the human transcriptome 7.25
RNAseq to determine whether bidirectional transcription occurs over transposable elements following depletion of SETDB1 in THP-1 AML Cells 7.11
Retinoic Acid Induced Transcriptional Repressor HIC1 is Required for Suppressive Function of Human Induced Regulatory T cells [RNA-Seq 1] 7.03
A Stable Transcription Factor Complex Nucleated by Dimeric AML1-ETO Controls Leukaemogenesis 7.03
Identification of a dynamic core transcriptional network in t(8;21) AML regulating differentiation block and self-renewal [RNA-Seq] 6.81
Identification of a dynamic core transcriptional network in t(8;21) AML regulating differentiation block and self-renewal 6.81
Agonistic targeting of TLR1/TLR2 induces p38 MAPK-dependent apoptosis and NfkB-dependent differentiation of AML cells 6.78
Identification of the networks that regulate human monocytic myeloid-derived suppressor cell differentiation into inflammatory macrophages 6.73
Dual modulation of neuron specific microRNAs and the REST complex promotes functional maturation of induced human adult neurons 6.68
MAIT cell RNA sequencing 6.67
AML subtype is a major determinant of the association between prognostic gene expression signatures and their clinical significance. 6.56
Innate-like activation of mucosal-associated invariant T cells in mycobacterial infection 6.52
SETDB2 links E2A-PBX1 to cell cycle dysregulation in acute leukemia through CDKN2C repression [sequencing] 6.47
Role of miR-146a in neural stem cell differentiation and neural lineage determination: relevance for neurodevelopmental disorders 6.43
Transcriptomic analysis of primary human T cells and murine RAW 264.7 macrophages 3D cultured in different collagen densities 6.33
mRNA expression profile of Lymphocytes by high-throuput sequencing 6.33
Consequences of Ribosomal Protein Haploinsufficiency in Human Hematopoiesis 6.26
A novel CD4+ T cell population expanded in SLE blood provides B cell help through IL10 and succinate 6.24
Effect of ROQUIN2(Y691F) expression on mRNA levels upon BCR stimulation 6.05
Dynamics of Proteo-Transcriptomic Response to HIV-1 Infection 6.03
RNA sequencing analysis of triple cytokine-captured human CD4 T cells 6.01
Transcriptome landscape of human primary monocytes response upon different ligand glucocorticoids 5.94
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor [human RNA-seq] 5.93
Regeneration of the lung alveolus by an evolutionarily conserved epithelial progenitor. 5.93
Transcriptome Analysis of PBMCs in peripheral blood of patients with hepatocellular carcinoma 5.89
Single Cell Analysis Reveals Unexpected Transcriptional Heterogeneity of Neural Progenitors in the Developing Human Cortex 5.76
Salmonella activation of STAT3 signaling by SarA effector promotes intracellular replication and production of IL-10 5.69
Chromatin remodeling mediated by ARID1A is indispensable for normal hematopoiesis in mice (human RNA-Seq) 5.62
Respecifying human iPSC-derived blood cells into highly engraftable hematopoietic stem and progenitor cells with a single factor 5.6
RNASeq of MV4;11 cells transduced with scramble shRNA or BRD4 shRNA in combination with DMSO or SGC0946 5.55
Identification of Tissue-Specific Protein-Coding and Noncoding Transcripts across 14 Human Tissues Using RNA-seq 5.52
RNA sequencing of ESC/iPSC-derived purified PAX6-GFP neural progenitors form control and Phelan-Mcdermid patients 5.48
Next Generation Sequencing Facilitates Quantitative Analysis of transcriptomes of human cord blood CD34+ cells treated with HDAC5 inhibitor 5.42
CRIG identifies a novel population of highly phagocytic peritoneal macrophages associated with disease severity in patients with cirrhosis and ascites 5.27
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells 5.25
Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells [RNA-seq] 5.25
RNA-seq analysis of activated plasmacytoid dendritic cell subsets after viral infection 5.24
The role of antigen presenting cells in the induction of HIV-1 latency in resting CD4+ T-cells 5.23
Tyrosine-1 of RNAPII CTD controls global termination of gene transcription in mammals 5.21
Next Generation Sequencing Quantitative Analysis of Wild Type and AML1-ETO Related Fusion Circular RNA (F-CircAE) Knockdown Kasumi-1 Cells Transcriptomes 5.21
The Polycomb Repressor Complex 1 Drives Double-Negative Prostate Cancer Metastasis by Coordinating Stemness and Immune Suppression 5.2
RNA-Seq study of Cell lines rendered resistant to idelalisib and ibrutinib 5.17
m6A level and isoform characterization sequencing (m6A-LAIC-seq) reveal the census and complexity of the m6A epitranscriptome 5.17
Small-molecule targeting of brachyury transcription factor addiction in chordoma 5.13
RNA-seq analysis reveals endogenous aryl hydrocarbon receptor regulation is highly associated with eicosanoid synthesis and tumor necrosis factor activity in MCF-7 cancer cells 5.12
Sequencing of matched pair samples (diagnosis and relapse) in human B-cell acute lymphoblastic leukemia cells (ALL) 5.1
Reprogramming of Endothelium Into Hematopoietic Progenitors by Defined Factors and Vascular Induction 4.96
Genome-wide analysis of YAP and TFCP2 occupancy and regulated expression in liver cancer cells 4.88
Genome-wide analysis of YAP and TFCP2 down-regulated genes in liver cancer cells 4.88
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming 4.88
The mithralog EC-7072 is highly cytotoxic to chronic lymphocytic leukemia cells by targeting the B-cell receptor signaling pathway 4.87
Selective expansion of myeloid and NK cells in humanized mice yields human-like vaccine responses (Experiment 1: RNA-seq) 4.85
Genome-wide CRISPR-Cas9 screen identifies druggable synthetic lethality between LSD1 and MTORC1 in MLL-translocated AML 4.76
The evolution of N6-methyladenosine in primates 4.72
Transient stabilization, rather than inhibition of MYC amplifies extrinsic apoptosis and therapeutic responses in refractory B-cell lymphoma 4.71
TAF1 is critical for AE driven leukemogenesis 4.71
TAF1 is critical for AE driven leukemogenesis [RNA-seq] 4.71
Specific modulation of HIV RNA splicing and upregulation of anti-inflammatory miR-124 by the new drug candidate ABX464 4.68
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. Tested on 5 concentrations. 4.6
RNA-sequencing time course of Human Intestinal Epithelial Cells (HIECs) following knockdown of miR-30bcd using complementary locked nucleic acids 4.53
Epigenomic profiling reveals the key function of histone H3K9 methylation during tumor transformation process 4.51
Next Generation Sequencing Facilitates Quantitative Analysis of HIV-1 Latency in Central Memory T Cells 4.5
Silencing SPIB in attached and floating state of H1703 lung cancer cells 4.49
Transcriptome analysis revealed impaired cAMP responsiveness in PHF21A-deficient human cells 4.49
Robust prediction of response to immune checkpoint blockade therapy in metastatic melanoma 4.47
METTL3 promotes translation in human cancer cells 4.46
Antibodies That Convert Bone Marrow Into Trafficking Microglia-Like Cells Reduce Brain Amyloid 4.46
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors [RNA-seq] 4.45
Hit-and-run epigenetic editing prevents senescence entry in primary breast cells from healthy donors 4.45
Transcriptional changes in lymphoma cells induced by LSD1 depletion 4.44
Histone demethylase LSD1 is required for germinal center formation and BCL6 driven lymphomagenesis 4.44
Global Gene Expression analysis of CUTLL1 cell lines after treatment with Perhexiline 4.43
Differential expression of long non‑coding RNA and mRNA in children with Henoch‑Schönlein purpura nephritis 4.31
Catalogue of differentially expressed long non-coding RNAs following activation of human and mouse innate immunity 4.26
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_sgrna] 4.19
Transcriptome analysis of peripheral blood monocytes 4.17
Lyophilized human cells stored at room temperature preserve multiple RNA species at excellent quality for RNA sequencing 4.16
MLL-AF4 binds directly to a BCL-2 specific enhancer and impacts H3K27 acetylation 4.16
Intrinsic Plasma Cell Differentiation Defects in BENTA Patient B cells 4.15
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers (RNA-Seq) 4.15
Transcriptional Down-regulation of CCR5 in a Subset of HIV+ Controllers 4.15
List of TIAM1 differentially expressed genes in SW620 cells [RNA-seq] 4.09
The inhibitory effect of TIAM1 on TAZ transcriptional activity and TIAM1 differentially expressed genes 4.09
Physiologic expression of Sf3b1K700E causes impaired erythropoieses, aberrant splicing, and sensitivity to pharmacologic spliceosome modulation 4.08
MEIS1 regulates hematopoiesis in hPSCs 4.08
RNA-sequencing of the GSI treatment of the CUTLL1 cell line 4.08
Targeting the androgen receptor N-terminus via the cochaperone Bag-1L 4.07
RNA seq analysis of human macrophages after treatment of glimepiride versus empagliflozin. 4.07
Microglia innatly develop within cerebral organoids 4.03
RNA sequencing of human macrophages treated with iron chelator deferiprone (DEF), with and without lipopolysaccharide (LPS) 4.02
Expression Analysis of dic(1;7)(q10;p10) in Myelodysplastic Syndromes (MDS) compared to control cohort and therapy-related Myeloid Neoplasms (t-MN) 4.01
A Distinct Epigenetic Program Underlies the 1;7 Translocation in Myelodysplastic Syndromes (MDS) 4.01
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation 3.97
T-bet recruits P-TEFb to super-enhancers to regulate T helper cell differentiation (RNA-Seq) 3.97
CAR T cell trogocytosis and cooperative killing regulate tumour antigen escape 3.94
Whole Transcriptome RNASeq Data for Cell-Sorted Antibody Secreting Cells (ASC) 3.92
Genome-wide Gene Expression Profiling in DLBCL Cell Lines Treated with CUDC-907 3.89
Capturing the biology of mild versus severe disease in a pluripotent stem cell-based model of Familial Dysautonomia 3.85
Rational targeting of cooperating layers of the epigenome yields enhanced therapeutic efficacy against AML 3.83
Transcriptomic analysis of senescent cells upon PTBP1 knockdown and EXOC7 knockdown 3.83
RNA-seq of stable and unstable section of human atherosclerotic plaques 3.82
RNA expression profiling of human mPB or CB-derived CD34+ cells treated with UM171 at different doses 3.78
NR4A1 Inhibition Synergizes with Ibrutinib in Killing Mantle Cell Lymphoma Cells 3.78
RNA-seq analysis of umbilical cord blood cells upon knockdown of NAP1L3 3.76
Sorted MDMs with RFP+GFP+ or RFP+GFP- Mtb 3.74
Bone marrow derived human B cells [normal proB] 3.72
Transcriptomic responses to Ivacaftor and prediction of Ivacaftor clinical responsiveness 3.63
Cyclophosphamide (CTX) Enhances Cancer Antibody Immunotherapy in the Resistant Bone Marrow Niche by Modulating Macrophage FcγR Expression 3.61
The Notch driven long non-coding RNA repertoire in T-cell acute lymphoblastic leukemia 3.57
Effect of selective glucocorticoid receptor modulation (SGRM) on gene expression in human prostate cancer cell lines 3.57
Short-term effect of Boost versus Radical doses of Intraoperative electron Radiotherapy in breast cancer tumor bed using high-throughput approaches 3.56
Transcriptomic profiling of mRNA and miRNA from nasopharyngeal carcinoma (NPC) and normal control samples 3.56
Transcriptomic profiling of nasopharyngeal carcinoma (NPC) and normal control samples 3.56
The mechanism of HHT in treating acute myeloid leukemia on RNA level. 3.55
Arrayed molecular barcoding identifies TNFSF13 as a positive regulator of acute myeloid leukemia-initiating cells 3.51
Epigenetic programming during monocyte to macrophage differentiation and trained innate immunity 3.51
Luminal lncRNAs Regulation by ERα-controlled Enhancers in a Ligand-independent Manner in Breast Cancer Cells 3.51
Effect of mitochondria deficiency on senescence-associated gene expression 3.49
circRNA profile in hypopharyngeal cancer 3.47
The transcriptomic differences between Th1, Tr1, and Tneg cells in controlled human malaria infection 3.44
mRNA profiles of JMJD3 overexpression- and JMJD3 knockout- HL-60 cells 3.44
Transcriptomes change differerntly in differernt cancer cells upon EPZ-6438 treatment 3.43
RNA-sequencing of highly pure synovial tissue macrophages reveals two distinct osteoarthritis subgroups that indicate different disease mechanisms. 3.42
Generation of mature lung alveolar epithelial cells from human pluripotent stem cells 3.36
Diffuse Large B Cell Lymphoma cell line with Acquired Resistance to PI3Kδ Inhibitor Idelalisib 3.35
Transcriptome analysis of SH-SY5Y cells after knockdown of circSLC45A4 3.34
IRF2 is a master regulator of human keratinocyte stem cell fate 3.34
IRF2 is a master regulator of human keratinocyte stem cell fate [RNA-seq] 3.34
Bladder cancer associated mutations in RXRA activate peroxisome proliferator-activated receptors 3.31
Bladder-cancer-associated mutations in RXRA activate peroxisome proliferator-activated receptors to drive urothelial proliferation 3.31
A Hybrid Mechanism of Action for BCL6 in B Cells Defined by Formation of Functionally Distinct Complexes at Enhancers and Promoters 3.31
Therapy-induced hypoxia contributes to AML drug-resistance through BMX Kinase upregulation 3.29
Transcriptome wide analysis of classically and alternatively activated macrophages 3.28
Bacterial Infection Remodels the DNA Methylation Landscape of Human Dendritic Cells (wtRNA-Seq) 3.27
Musashi-2 attenuates AHR signalling to expand human haematopoietic stem cells 3.27
Critical role for Lymphocytes in Producing FLT3LG in Tumors and Driving Checkpoint Therapy-Receptive Immune Microenvironments 3.23
SAMHD1 is recurrently mutated in T-cell prolymphocytic leukemia [RNA-seq] 3.21
RNA-Seq gene profiling comparison from human cDC subsets and pre-cDC subsets 3.15
Connexin 32-mediated cell-cell communication is essential for hepatic differentiation from human embryonic stem cells 3.1
Dynamics of the human and viral m6A RNA methylomes during HIV-1 infection of T cells 3.1
RNA-seq transcriptional profiling in primary human erythroid progenitor cells upon shRNA-mediated knockdown of PRC2 core subunits 3.1
ChIP-seq and RNA-seq analysis of PRC2 core subunits in primary human erythroid progenitor cells 3.1
H3K27ac ChIP-Seq and mRNA-Seq analysis of five human B-lymphoblastoid cell lines (LCLs) prepared from the same healthy male individual (CEPH/UTAH). 3.09
Polarized B -cell functions 3.09
Characterization of human ILC2 subsets 3.05
Global transcript structure resolution of high gene density genomes through multi-platform data integration: Illumina RNA-Seq 3.03
NR2F2 study 3.03
Estrogen response in breast cancer cell line MCF-7 is dependent on NR2F2 [RNA-seq] 3.03
Study functions of ADAR proteins using next generation sequencing of genome and transcriptome 2.98
Comparison of the transcriptome and chromatin state between human cord blood HSC and human iPSC derived hematopoietic progenitor using next-generation sequencing 2.94
Primate transcript and protein expression levels evolve under compensatory selection pressures 2.93
Transcription differences in DLBCL cell lines U2932, DOHH2 on treatment with TK compound compared to DMSO 2.9
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma 2.88
Enhancer Sequence Variants and Transcription Factor Deregulation Synergize to Construct Pathogenic Regulatory Circuits in B Cell Lymphoma (RNA-Seq) 2.88
Integrated high-throughput screen to identify novel treatment leads for pediatric acute myeloid leukemia (AML) 2.84
Progressive motor neuron pathology and the role of astrocytes in a human stem cell model of VCP-related ALS 2.83
RNA-sequencing of human tendon after injury 2.76
RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 2.76
RNA-seq and small RNA-seq analysis of BORIS/CTCFL knockdown in K562 cell line 2.76
Molecular Biomarkers Screened by Next-generation RNA Sequencing for non-sentinel lymph node status predicting in breast cancer patients with metastatic sentinel lymph node 2.72
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-PBS / R-2HG treatment 2.71
Mucosal Profiling of Pediatric-Onset Colitis and IBD Reveals Common Pathogenics and Therapeutic Pathways 2.67
Novel Non-catalytic Substrate-selective p38α-specific MAPK Inhibitors with Endothelial-Stabilizing and Anti-inflammatory Activity 2.65
Identifying a novel candidate diagnostic and prognostic biomarker SPRR3 for oral squamous cell carcinoma via mRNA Sequencing and Bioinformatics 2.65
Irf9 function in immunity in mouse 2.63
Transcription profile analysis of wild type and Irf9-/- human monocytic THP1 cells in response to type I interferons 2.63
A practical evaluation of alignment algorithms for RNA variant calling analysis 2.61
Identification of novel recurrent ETV6-IGH fusions in primary central nervous system lymphoma using high throughput RNA sequencing 2.6
5hmC and gene expression data in breast cancer cell lines treated with an antioxidant 2.58
CDK4/6 inhibitor resistance in prostate cancer 2.57
Single cell RNA sequencing reveals microglia-like cells in cerebrospinal fluid  during virologically suppressed HIV 2.57
Seletive inhibition of CDK9 in DLBCL cell lines 2.56
IL-6/Stat3-Dependent Induction of Distinct, Obesity-Associated Natural Killer Cells Deteriorates Energy and Glucose Homeostasis 2.55
High-depth RNA sequencing of isogenic wild-type, PIK3CA-WT/H1047R and PIK3CA-H1047R/H1047R human iPSCs 2.55
RNA-Seq profiling in PBMCs and spinal cord from ALS patients and healthy controls 2.55
Comprehensive RNA-Seq profiling in PBMCs of ALS patients and healthy controls 2.55
Transcriptomes in healthy and CHB fetal hearts 2.54
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with pancreatic carcinoma 2.52
Sirt6 Oncogene Mediates PI3K/Akt Signaling Activation in Diffuse Large B-Cell Lymphoma 2.51
RNA Sequencing Facilitates Quantitative Analysis of Transcriptomes of H1 and H1 after SNAI1 deletion at Day2 after human early hematopoietic differentiation . 2.5
MicroRNA-125a-5p overexpression in human macrophages 2.49
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation [RNA-seq] 2.49
Co-Stimulation–Induced AP-1 Activity is Required for Chromatin Opening During T Cell Activation. 2.49
Human CD11b+ macrophages - Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 2.49
Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 2.49
Human Bone Marrow Assessment by Single Cell RNA Sequencing, Mass Cytometry and Flow Cytometry [bulk] 2.48
A Primate lncRNA Mediates Notch Signaling During Neuronal Development by Sequestering miRNA [SHSY5Y cells] 2.47
RNA-Seq of CD4+ T cells treated with AS1842856 or DMSO 2.45
Dual inhibition of HDMX and HDM2 as a Therapeutic Strategy in Leukemia 2.42
Sequencing of messenger RNAs with N6-methyladenosine modifications in acute myeloid leukemia (AML) with and without forced expression of FTO 2.42
Hematopoietic Stem and Progenitor Cells from Human Pluripotent Stem Cells via Transcription Factor Conversion of Hemogenic Endothelium 2.39
The regulation of ferroptosis by TAZ in epithelial ovarian cancer 2.34
RNA-Seq of SLNCR1 over-expression in the melanoma cell line A375 2.34
Single cell transcriptome of peritoneal cells 2.33
RNA-seq in neurons derived from iPSCs in controls and patients with schizophrenia and 22q11 del 2.29
Transcriptomic analysis of senescent cells upon PTBP1 knockdown. 2.27
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and SMAD4 Y95 Mutation Transcriptomes 2.26
Cerebral Organoids Recapitulate Epigenomic Signatures of the Human Fetal Brain 2.22
PTHrP overexpression in MCF7 cells 2.22
RNA-Seq characterization of human H1-derived NPC differentiation timecourse 2.21
Efficient derivation of microglia-like cells from human pluripotent stem cells 2.2
Molecular Hallmarks of Experimentally Acquired Immunity to Malaria [Pilot Study] 2.18
Heterogeneous maintenance of human tissue resident memory T cells based on efflux capacities 2.17
Antibiotics induce polarization of pleural macrophages to M2-like phenotype in patients with tuberculous pleuritis 2.09
SHANK2 mutations associated with autism spectrum disorder cause hyperconnectivity of human neurons 2.08
FOXP3 protects conventional human T cells from premature restimulation-induced cell death 2.05
Generation and functional characterization of MDSC-like cells 2.05
JAK/STAT inhibition in macrophages promotes therapeutic resistance by inducing expression of protumorigenic factors 2.05
RNA-Seq and expression data from human adipose tissue 2.02
Tissue-specific RNA-seq in human evoked inflammation identifies novel blood and adipose lincRNA signatures of cardio-metabolic diseases 2.02
Complement protein C1q modulates macrophage molecular signaling and inflammatory responses during ingestion of atherogenic lipoproteins 2.0
Thyroid State Regulates Gene Expression in Human Whole Blood Cells 2.0
REPROGRAMMING IDENTIFIES FUNCTIONALLY DISTINCT STAGES OF CLONAL EVOLUTION IN MYELODYSPLASTIC SYNDROMES 1.99
RNA-sequencing of fibrolamellar carcinoma (FLC) cell line treated with miR-375 mimic 1.98
Effects of rFVIIIFc on human macrophages 1.97
Trascriptome of thyroid cancer-induced macrophages 1.94
RNA profiling Analysis of the Serum Exosomes Derived from Active and Latent M.tuberculosis infectious Patients 1.94
Overexpression of ERG in cord blood progenitors promotes expansion and recapitulates molecular signatures of high ERG leukemias 1.92
The ZZ-type zinc finger of ZZZ3 modulates the ATAC complex-mediated histone acetylation and gene activation 1.91
RNA sequencing of Formalin-Fixed, Paraffin-Embedded Specimens for Gene Expression Quantification and Data Mining 1.91
Simultaneous profiling of sexually transmitted bacterial pathogens, microbiome, and concordant host response in cervical samples using whole transcriptome sequencing analysis 1.91
Migration through a small pore disrupts inactive chromatin organisation in neutrophil-like cells [RNA-seq] 1.9
RNA-seq and Hi-C sequencing of neutrophil-like cells migrated through large or small pores 1.9
Alarmin S100A11 initiates a chemokine response to the human pathogen Toxoplasma gondii 1.88
RNA-seq on Enasidenib or DMSO Treated CD71+ Cells from Umbilical Cord Blood (UCB) 1.88
RNAseq of human monocyte cell line (U937-Cas9) WT or IRF2KO 1.87
NAPRT activation of macrophages 1.8
Global transcriptome analysis in the MYCN-amplified neuroblastoma cell line IMR5-75 upon inducible MYCN-knockdown 1.8
RNA sequencing data of whole blood cells of normal glucose tolerant (NGT) and gestational diabetes (GDM) pregnant women 1.8
The CDK7 Inhibitor THZ1 Alters RNA Polymerase Dynamics at the 5’ and 3’ Ends of Genes 1.79
Total RNA was extracted from three samples of CD33 CAR or control T cells from three different donors 1.79
Transcriptome analysis of diverse cell types infected with human cytomegalovirus [RNA-Seq] 1.75
The dynamic landscape of coding and non-coding RNAs in the innate immune response to microbial pathogens 1.74
Novel Transcriptional Activity and Extensive Allelic Imbalance in the Human MHC Region 1.73
Efficient direct reprogramming of c-Kit− mature amniotic cells into endothelial cells by ETS factors and TGFβ suppression 1.72
Modulation of SF3B1 causes global intron retention and downregulation of the B-cell receptor pathway in chronic lymphocytic leukemia 1.7
Epigenomes and transcriptomes of human monocytes before and after in vivo exposure to Bacillus Calmette-Guérin vaccine 1.69
Effect of venetoclax, tedizolid, and combination treatment on gene expression in a venetoclax-resistant AML cell line 1.69
Zika virus antagonizes interferon response in patients and disrupts RIG-I-MAVS interaction through its CARD-TM domains 1.69
Zoledronic acid inhibits NFAT and IL-2 signaling pathways in regulatory T cells and diminishes their suppressive function in patients with metastatic cancer 1.68
Human lymph nodes maintain a unique subset of resident memory T cells with high functional potential important for protective immunity and immunotherapies 1.66
Long non-coding RNA RP11-19E11.1 is an E2F1 target required for tumor cell proliferation and survival in basal breast cancer 1.64
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures [RNA-seq] 1.64
Tumor- and cytokine-primed human natural killer cells exhibit distinct phenotypic and transcriptional signatures 1.64
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid [TEMRA] 1.63
Clonally expanded CD8 T cells patrol Alzheimer's cerebrospinal fluid 1.63
Identification of long noncoding RNAs in T-ALL cell lines 1.59
Inhibiting the oncogenic translation program is an effective therapeutic strategy in multiple myeloma 1.59
Ex-vivo Human Hematopoietic Stem Cell Expansion Requires Coordination of Cellular Reprogramming with Mitochondrial Remodeling and P53 Activation [bulk] 1.54
Functional separation of IL7Rα/KLRG1-defined CD8+ T cell populations in humans 1.53
A next generation sequencing based approach to identify extracellular vesicle mediated mRNA transfers between cells 1.53
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML 1.52
MEIS2 is a novel oncogenic partner in AML1-ETO positive AML [RNA-Seq human] 1.52
CD48-dependent protective autophagy in conventional human T cells promotes restimulation-induced cell death resistance 1.49
Self-associated molecular patterns mediate cancer immune evasion by engagement of Siglec receptors 1.46
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma [RNA-seq] 1.44
INO80 governs super-enhancer-mediated oncogenic transcription and tumor growth in melanoma 1.44
Reprogrammed myeloid cell transcriptomes in NSCLC 1.43
Non-inflammatory tumor microenvironment of Diffuse Intrinsic Pontine Glioma (DIPG) 1.37
Multidimensional Assessment of the Host Response in Mechanically Ventilated Patients with Suspected Pneumonia 1.37
Specific inhibition of DPY30 activity by peptides suppresses blood cancer cell growth 1.36
Human interleukin-4 treated regulatory macrophages promote epithelial wound healing and reduce colitis in an mouse model 1.36
Profiling of lung tumor-infiltrating CD8 T cells according to their expression status of CD39 1.36
Alternative classification of glioblastoma based on BUB1B-inhibition sensitivity 1.36
Research resource: global identification of estrogen receptor β target genes in triple negative breast cancer cells 1.35
Transcriptome splicing analysis in K562 cells expressing rare and private spliceosomal mutations 1.34
The anti-leukemic effect of R-2HG depends on its acting as an m6A mRNA modifier-RNA Seq-Resistant, sensitive and healthy control 1.33
Transcriptomes of human monocytes after ex vivo exposure to uric acid 1.31
Gene expression profile of differentially recognized Mtb-epitopes as a function of disease history 1.3
RNA-seq, ChIP-seq and single cell RNA-seq of human skin Langerhans cells 1.29
Networks of cultured iPSC-derived neurons reveal the human synaptic activity-regulated adaptive gene program 1.29
A monocyte gene expression signature in the early clinical course of Parkinson’s disease 1.28
Human Treg IL-12 stimulation 1.28
Long noncoding RNA signatures induced by TLR7 and type I IFN signaling in activated human plasmacytoid dendritic cells 1.27
Dissection of estrogen receptor alpha signaling pathways in osteoblasts using RNA-sequencing 1.26
JMJD3 facilitates C/EBPβ-centered transcriptional program to exert oncorepressor activity in AML 1.23
RNA Sequencing Analysis of villus tissues from unexplained recurrent spontaneous abortion patients and controls with induced abortions 1.21
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth [RNA-Seq] 1.17
ATXN7L3 And ENY2 Coordinate Activity Of Multiple H2B Deubiquitinases Important For Cellular Proliferation And Tumor Growth 1.17
RNA-sequencing study of peripheral blood monocytes for chronic periodontitis 1.16
Whole transcriptome profile of citrulline-specific B cells from patients with rheumatoid arthritis 1.15
RNA-sequencing of the human milk fat layer during colostrum, transitional, and mature stages of lactation 1.15
ZNF804A transcriptome networks in differentiating human neurons derived from induced pluripotent stem cells 1.14
Transcriptome sequencing of a large human family identifies the impact of rare non-coding variants 1.14
Functional characterization of human T cell hyporesponsiveness induced by CTLA4-Ig 1.11
Expression levels of genes of NKG2C+ NK cells after in vitro treatment 1.08
CRISPR/Cas9 Screens Reveal Epstein-Barr virus Synthetic Lethal Targets 1.07
PSEN1ΔE9, APPswe and APOE4 confer disparate phenotypes in human iPSC-derived microglia 1.05
Global reduction in H3K27me3 and DNA hypomethylation define poorly prognostic pediatric posterior fossa ependymomas 1.03
Targeted enhancer activation by a subunit of the integrator complex 1.01
Analyses of T-ALL (COG study) 1.0
RNA sequencing of T-ALL (COG study) 1.0
Functional studies of missense TREM2 mutations in human stem cell-derived microglia 1.0
A faithful in vivo model of human MLL-AF4 proB acute lymphoblastic leukemia 0.99
PRMT5 Interacts with the BCL6 Oncoprotein and is Required for Germinal Center Formation and Lymphoma Cell Survival 0.98
KSRP specifies monocytic and granulocytic differentiation through regulating miR-129 biogenesis and RUNX1 expression 0.97
Identification of Differentially Expressed Splice Variants by the Proteogenomic Pipeline Splicify 0.97
Viral infection enhances NK cell activation via Type I dependent pathways and can be utilized to enhance influenza-specific monoclonal antibody therapies 0.97
RNA-seq of exosomes identifies lncRNA profiles that distinguish early-stage esophageal squamous cell carcinoma (ESCC) from non-malignant esophagitis 0.97
Multi-platform assessment of transcriptional profiling technologies utilizing a precise probe mapping methodology 0.95
BACH2 in human plasma cell fate decision 0.94
Expression of the mannose receptor (CD206) defines distinct populations of human colonic macrophages in health and inflammatory bowel disease 0.9
MCF-7 as a model for functional analysis of breast cancer risk variants 0.87
Transcriptome of activated human and mouse MAIT cells 0.84
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with colorectal carcinoma 0.84
Zika virus infection reprograms global transcription of host cells to allow sustained infection 0.83
Temporal comparison of transcriptomic alterations in human, mouse and rat primary B lymphocytes exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) 0.8
RNA-Seq in PWS iPSC-derived neurons 0.77
Expression analysis of THP1 cells following shRNA knock-down of RUVBL2 0.75
FGF2 regulation of gene expression in stable inducible Neurons 0.75
Generation and persistence of human tissue-resident memory T cells in lung transplantation 0.74
Transcriptomics profiling of CD141+ dendritic cells isolated from peripheral blood or synovial fluid of arthritis patients 0.74
The cytokine environment influence on human skin-derived T cells 0.73
Quantitative Proteomics Reveals a Unique Wiring of Signaling Pathways that Protects Human Regulatory T Cell Identity 0.71
HSB-2 cells stably expressing LDB1 or mutant LDB1 proteins 0.7
Clinker: visualizing fusion genes detected in RNA-seq data 0.68
Transcriptome analysis of CD8+ T cells from healthy controls and patients wth CD46 deficiency 0.68
Analysis of transcriptomes of healthy donor and CD46 deficient CD8 T cells 0.68
AQP5-Expressing Cells Serve as Stem Cells and Cancer Origins in the Distal Stomach 0.67
Functional significance of the HIV-1 Tat signature amino acid residues 0.66
Genome-wide RNA deep sequencing of CAL-101 or AKTi primed human T cells in comparison to traditionally expanded T cells 0.65
Antiviral and anti-inflammatory properties of novel anti-HIV candidate ABX464 promotes specifics RNA splicing while preserving cellular RNA integrity. 0.65
The Regulation of IFN Type I Pathway Related Genes RSAD2 and ETV7 Specifically Indicate Antibody-Mediated Rejection After Kidney Transplantation 0.65
JMJD1C is required for the survival of acute myeloid leukemia by functioning as a co-activator for key transcription factors 0.65
RNA expression analysis upon JMJD1C depletion 0.65
Tri-mannose grafting of chitosan nanocarriers remodels the macrophage response to bacterial infection 0.64
Gene expression profiling of leukemia cells following asparagine depletion 0.62
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function [RNAseq] 0.61
Epigenetic reprogramming of immune cells in women with PCOS impact genes controlling reproductive function 0.61
CD161+ Tconv and Treg share transcriptome and display a migratory phenotype which is modified at the inflamed site 0.59
Organelle-based therapy for immune mediated disease: mitochondrial transfer elicits Tregs reprogramming 0.59
Gene expression in TAL1-driven T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 0.58
T-cell ALL in response to TAL1-KD, UTX-KD, and GSKJ4 treatment 0.58
CD74 role in transcription regulation 0.57
CD74 role in transcription regulation [RNA-seq] 0.57
A novel tumor-associated myeloid cell population inhibits antigen-specific immune responses in cancer patients 0.57
The RNA binding protein IGF2BP3 promotes hematopoietic progenitor cell proliferation by targeting leukemogenic pathways 0.57
Impact of Escherichia coli K12 and O18 on human platelets: effects on platelet activation, spliced platelet RNAs and proteins 0.56
Chronic Myeloid Leukemia (CML), induced pluripotent stem cell (iPSC)-derived lin-CD34+CD45+ (iCD34) cell population 0.56
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. [RNA-Seq] 0.56
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. 0.56
Interferon-beta-inducible genes in human monocyte-derived macrophages (MDMs) 0.56
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 [RNA-seq] 0.5
C/EBPα overexpression overrides epigenetic reprogramming by RUNX1-ETO and RUNX1-EVI1 0.5
Dynamic gene regulatory networks of human myeloid differentiation [RNA-seq_siRNA] 0.49
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction [RNA-seq] 0.49
YY1 haploinsufficiency causes an intellectual disability syndrome featuring transcriptional and chromatin dysfunction. 0.49
Acetylation of spliceosome protein PHF5A modulates stress responses and colorectal carcinogenesis through alternative splicing mediated upregulation of KDM3A 0.49
naive T cell heterogeneity after neonatal thymectomy 0.47
Gene expression activation in CLL mediated by MSCs contact 0.47
Time-dependent regulation of cellular programming of monocytes by NCOR2 [RNASeq_TK] 0.45
RNAi profiling of primary human AML cells identifies ROCK1 as a therapeutic target and nominates Fasudil as an anti-leukemic drug. 0.44
IL-6 augments IL-4-induced polarization of primary human macrophages through synergy of STAT3, STAT6 and BATF transcription factors 0.43
Gene expression for surgically treated pancreatic cancer after one neoadjuvant vaccine dose 0.42
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing 0.37
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing (RNA-seq) 0.37
Next generation sequencing of the transcriptome in MCF-7 cells with/without SRA knockdown 0.36
RNA deep sequencing to compare genome-wide differences between PRMT5/knockdown and control AML cells 0.36
RNASeq of Arg2 gRNA or scrambled gRNA CRISPR'd Tregs 0.34
Transcriptomics-based drug repurposing approach identifies novel drugs against sorafenib-resistant hepatocellular carcinoma 0.33
RNAseq of CD8+ and CD8- MAIT cells in human peripheral blood 0.31
Frailty in middle age is associated with race-specific changes to the transcriptome. 0.28
Transcriptome analysis of diverse cell types infected with human cytomegalovirus 0.27
Oncogenic roles of ARID5B in T-ALL 0.26
RNA-seq analysis in knockdown Jurkat samples for each factor of TAL1 complex 0.26
RNA-seq of primary patient AML samples 0.26
ALS implicated protein TDP-43 sustains levels of STMN2 a mediator of motor neuron growth and repair 0.25
MHC Transcriptomic landscape at haplotype-specific resolution 0.22
DDX54 regulates transcriptome dynamics during DNA damage response [RNA-seq2] 0.21
Effects of transcription factor CEBPA knockdown on vitamin D target gene regulation in THP-1 cells 0.21
The pioneer factor CEBPA modulates vitamin D signaling 0.21
B-cell activating factor (BAFF) stimulation of Burkitt Lymphoma cell line [RNA-Seq] 0.2
Next Generation Sequencing for Quantitative Analysis of transcriptome of follicular compared to non-follicular CD8 T cells from HIV+ Lymph nodes 0.19
Transcriptome profiling (RNA-seq) of CREBBP+/+ and CREBBP+/- clones of U2932 DLBCL cell line 0.18
A novel target of EZH1/2 for treatment of mantle cell lymphoma 0.17
Transcriptome of Primitive Human Hematopoietic Cells: A New Resource to Find hHSC-Specific Genes 0.14
Functional TRIM24 degraders via conjugation of ineffectual bromodomain and VHL ligands [RNA-seq] 0.11
Functional genomic analysis of the haploinsufficient tumor suppressor, CUX1 0.09
Characterisation of the myeloid differentiation process of human hematopoietic stem cells 0.07
circNFIB suppresses lymphatic metastasis of pancreatic cancer 0.07
The role of m6A/m-RNA methylation in stress response regulation 0.06
m6A/m-Seq of human B-lymphocyte cell lines from healthy controls and major depressive disorder patients 0.06
Longitudinal transcriptome profiling of post-treatment Lyme disease syndrome 0.04
The expression profiles of GBC liver metastasis 0.04
Specific molecular signatures underlie response to decitabine in CMML [RNA-seq] 0.03
Specific molecular signatures underlie response to decitabine in CMML 0.03
Analysis of gene expression in primary human foreskin keratinocytes +/- HPV16 E7 or PTPN14 knockout 0.02
RNA-seq of CD33 KO and control HSPCs 0.0


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation